Skip to main content

Study

Cannabigerol (CBG) May Reduce Anxiety and Stress in Adults

A recent study found that Cannabigerol (CBG) significantly reduced anxiety and stress without causing cognitive impairments.

Stress & AnxietyMental WellnessHerbal Remedies
Study Credibility: Medium7.2/10Some supporting evidenceStudy has limitationsUse with caution
PublishedSep 2026Last reviewedSep 2026
Email this

Summary

In plain language

A recent study explored the effects of Cannabigerol (CBG), a compound found in hemp, on anxiety, stress, and mood. Researchers found that CBG significantly reduced anxiety and stress levels compared to a placebo, without causing any noticeable side effects or cognitive impairments. This suggests that CBG might be a promising natural alternative for managing these conditions. For seniors, this could mean another option to explore for anxiety and stress relief, potentially offering benefits without the risks of traditional medications. Always discuss with your healthcare provider before trying new supplements.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study used a double-blind, placebo-controlled design, where neither the participants nor the researchers knew who received CBG or a placebo. Participants took part in two sessions and were given either a 20 mg dose of CBG or a placebo. The study found that CBG significantly reduced anxiety and stress levels and even improved verbal memory.

  • CBG did not cause any motor or cognitive impairments, making it potentially safe for seniors.

  • The study was conducted remotely with adult participants, ensuring a diverse sample.

  • While promising, more research is needed to confirm these findings in larger and more diverse populations.

Seniors should consult their healthcare providers to discuss the potential benefits and risks of using CBG for anxiety and stress management.

Research Quality Score

Scored September 27, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study scored highly in design and bias control due to its rigorous double-blind, placebo-controlled, crossover methodology. Statistical integrity was strong with pre-specified endpoints and adequate power. Transparency was ensured through pre-registration. However, conflicts of interest were not fully transparent, and the study's relevance to the target population was low as it focused on younger adults. Journal quality could not be assessed due to lack of information.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control10.0/10
Statistical methods10.0/10
Reporting completeness10.0/10
Conflicts & funding2.5/10
Replication0.0/10
Relevance to chosen population0.0/10
Journal Reliability5.0/10

Additional Notes

This study investigates the acute effects of cannabigerol (CBG) on anxiety, stress, and mood in a double-blind, placebo-controlled, crossover trial with 34 healthy adults. Results suggest CBG reduces anxiety and stress without causing intoxication or impairment.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.